Inspire Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Inspire Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34	Closed	-$1K	–	767
2020 Q4	$1K	Buy	+34	New	+$586	﹤0.01%	775

Other funds holding LUMO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Inspire Advisors's LUMO Position: Q1 2021 in Review

Inspire Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2021, closing a stake of 34 shares — an estimated $1K sold.

Inspire Advisors first reported a position in LUMO in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 41 funds tracked by Wall St. Rank hold LUMO as of Q1 2021.

Inspire Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Inspire Advisors sold 34 Lumos Pharma, Inc. Common Stock shares in Q1 2021, an estimated $1K.
Inspire Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Inspire Advisors's Lumos Pharma, Inc. Common Stock position peaked at $1K in Q4 2020.
41 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2021.

Based on Inspire Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.